- Trials with a EudraCT protocol (66)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
66 result(s) found for: Lower Gastrointestinal Bleeding.
Displaying page 1 of 4.
EudraCT Number: 2011-006056-37 | Sponsor Protocol Number: 1160.143 | Start Date*: 2013-09-05 | |||||||||||
Sponsor Name:Hamilton Health Sciences Corporation | |||||||||||||
Full Title: A large, international, randomized, placebo-controlled trial to assess the impact of dabigatran (a direct thrombin inhibitor) and omeprazole (a proton-pump inhibitor) in patients suffering myocardi... | |||||||||||||
Medical condition: MINS (myocardial injury after noncardiac surgery) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) IT (Completed) PT (Completed) ES (Completed) GB (Completed) AT (Completed) DE (Prematurely Ended) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001684-36 | Sponsor Protocol Number: GED0507-UC-001 | Start Date*: 2016-12-12 | ||||||||||||||||||||||||||
Sponsor Name:PPM SERVICES SA | ||||||||||||||||||||||||||||
Full Title: A PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF GED-0507-34-LEVO (GED0507) FOR TREATMENT OF SUBJECTS WITH ACTIVE ULCERATIVE COLITIS | ||||||||||||||||||||||||||||
Medical condition: Ulcerative Colitis | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: SK (Prematurely Ended) HU (Prematurely Ended) BG (Prematurely Ended) LV (Prematurely Ended) ES (Prematurely Ended) IT (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-000981-70 | Sponsor Protocol Number: 1408143 | Start Date*: 2016-03-08 |
Sponsor Name:Centre Hospitalier Universitaire de Saint-Etienne | ||
Full Title: A multicentre, randomised, double-blind, controlled, phase IIIb study to assess the efficacy and safety of Rivaroxaban 10mg od versus Enoxaparin 4000 IU for VTE PROphylaxis in NOn Major Orthopaedic... | ||
Medical condition: Venous Thromboembolism Prophylaxis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Ongoing) ES (Completed) CZ (Completed) NL (Completed) DE (Completed) GR (Completed) PL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2021-003085-12 | Sponsor Protocol Number: ANT-008 | Start Date*: 2022-05-10 |
Sponsor Name:Anthos Therapeutics | ||
Full Title: A multicenter, randomized, open-label, blinded endpoint evaluation, phase 3 study comparing the effect of abelacimab relative to dalteparin on venous thromboembolism (VTE) recurrence and bleeding i... | ||
Medical condition: venous thromboembolism (VTE) in patients with gastrointestinal/genitourinary cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: LV (Ongoing) NO (Ongoing) IE (Ongoing) ES (Ongoing) HU (Ongoing) IT (Ongoing) NL (Ongoing) SE (Ongoing) AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004032-19 | Sponsor Protocol Number: NLOCEAN.505.14 | Start Date*: 2015-09-09 |
Sponsor Name:Radboud University Medical Center | ||
Full Title: A randomised, open-label clinical trial assessing the efficacy of octreotide to decrease iron infusion and blood transfusion requirements in patients with refractory anaemia due to gastrointestinal... | ||
Medical condition: small bowel angiodysplasias | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004217-26 | Sponsor Protocol Number: CSUC-01/16 | Start Date*: 2017-04-21 |
Sponsor Name:InDex Pharmaceuticals AB | ||
Full Title: A Randomised Dose-Optimisation Study to Evaluate the Efficacy and Safety of Cobitolimod in Moderate to Severe Active Ulcerative Colitis Patients | ||
Medical condition: Moderate to Severe left-sided Active Ulcerative Colitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) HU (Completed) SE (Completed) ES (Completed) CZ (Completed) FR (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-001709-21 | Sponsor Protocol Number: 2020PI073 | Start Date*: 2020-04-29 | |||||||||||
Sponsor Name:CHRU de Nancy | |||||||||||||
Full Title: Effectiveness of low molecular weight heparin at increased doses prophylaxis weight-adjusted, compared with lower doses prophylaxis (intermediate or standard), on the onset of venous thromboembolis... | |||||||||||||
Medical condition: Prevention of thromboembolic events in hospitalised COVID-19 infected patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001571-21 | Sponsor Protocol Number: P18.037 | Start Date*: Information not available in EudraCT |
Sponsor Name:Leiden University | ||
Full Title: Training immune functions through pharmacotherapeutic conditioning in juvenile idiopathic arthritis | ||
Medical condition: Juvenile Idiopathic Arthritis | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2011-004581-14 | Sponsor Protocol Number: A3921139 | Start Date*: 2012-06-29 | |||||||||||
Sponsor Name:Pfizer Inc. | |||||||||||||
Full Title: A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS | |||||||||||||
Medical condition: Ulcerative colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) DK (Completed) HU (Completed) EE (Completed) GB (Completed) LV (Completed) BE (Completed) NL (Completed) ES (Completed) AT (Completed) DE (Completed) SK (Completed) PL (Completed) IT (Completed) HR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004580-79 | Sponsor Protocol Number: A3921096 | Start Date*: 2012-02-24 | |||||||||||
Sponsor Name:Pfizer Inc, 235 East 42nd Street, New York, New York 10017 | |||||||||||||
Full Title: A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF ORAL CP-690,550 AS A MAINTENANCE THERAPY IN SUBJECTS WITH ULCERATIVE COLITIS | |||||||||||||
Medical condition: Ulcerative colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) CZ (Completed) HU (Completed) EE (Completed) GB (Completed) LV (Completed) BE (Completed) ES (Completed) AT (Completed) DE (Completed) PL (Completed) IT (Completed) SK (Completed) HR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004179-11 | Sponsor Protocol Number: 2018-4898 | Start Date*: 2019-06-03 |
Sponsor Name:Radboudumc | ||
Full Title: Effectiveness of Somatostatin Analogues in Patients with hereditary hemorrhagic telangiectasia and symptomatic gastrointestinal bleeding, the SAIPAN-trial: a multicenter, randomized, open-label, pa... | ||
Medical condition: Hereditary hemorrhagic telangiectasia (HHT) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) DE (Ongoing) FR (Ongoing) IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-003323-11 | Sponsor Protocol Number: ITIBU001 | Start Date*: 2014-10-01 | ||||||||||||||||
Sponsor Name:"Sapienza" University of Rome | ||||||||||||||||||
Full Title: RANDOMIZED CLINICAL TRIAL, PLACEBO-CONTROLLED, SPLIT-MOUTH, A DOUBLE-BLIND, FOR THE EVALUATION OF THE EFFECTIVENESS OF PREemptive ANALGESIA BY ADMINISTRATION OF IBUPROFEN 400MG, FOR THE CONTROL ... | ||||||||||||||||||
Medical condition: POST-OPERATIVE ACUTE PAIN (DAPO) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-002593-89 | Sponsor Protocol Number: TV48574-IMM-20038 | Start Date*: 2023-03-15 | ||||||||||||||||
Sponsor Name:Teva Branded Pharmaceutical Products R&D, Inc. | ||||||||||||||||||
Full Title: A 24-Week, Phase 2b, Randomized, Double-Blind Long-Term Extension Study to Evaluate Pharmacokinetics, Efficacy Safety, and Tolerability of TEV-48574 in Adult Patients with Moderate to Severe Ulcera... | ||||||||||||||||||
Medical condition: Moderate to severe Ulcerative colitis or moderate to severe Crohn's disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) CZ (Ongoing) SK (Ongoing) IT (Ongoing) BG (Ongoing) AT (Ongoing) HU (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004355-33 | Sponsor Protocol Number: MH002-UC-201 | Start Date*: 2021-09-23 | |||||||||||
Sponsor Name:MRM Health NV | |||||||||||||
Full Title: Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety, Mechanistic Effects, and Effects on Disease Activity of MH002 in Subjects with Mild to Moderate Ulcerative Colitis: A First-in... | |||||||||||||
Medical condition: Ulcerative Colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) CZ (Completed) PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-006174-47 | Sponsor Protocol Number: FC-004 | Start Date*: 2012-06-08 | |||||||||||
Sponsor Name:ProFibrix BV | |||||||||||||
Full Title: A Phase 3, Randomized, Single-Blind, Controlled Trial of Topical Fibrocaps™ in Intraoperative Surgical Haemostasis | |||||||||||||
Medical condition: Intraoperative Surgical Hemostasis (Spinal Surgery, Vascular Surgery, Hepatic resection, Soft tissue dissection) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) NL (Completed) GB (Completed) | |||||||||||||
Trial results: Removed from public view |
EudraCT Number: 2010-022766-27 | Sponsor Protocol Number: B3041001 | Start Date*: 2012-01-19 | |||||||||||
Sponsor Name:Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK | |||||||||||||
Full Title: A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTI-CENTER STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF MULTISTEM (PF-05285401) IN SUBJECTS WITH MODERATE TO SEVERE ULCE... | |||||||||||||
Medical condition: Ulcerative Colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) BE (Completed) HU (Completed) SK (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003700-18 | Sponsor Protocol Number: 20060131 | Start Date*: 2007-02-05 | |||||||||||
Sponsor Name:Amgen Inc. | |||||||||||||
Full Title: A Randomized, Controlled, Open- label Study Evaluating the Efficacy and Tolerability of AMG 531 versus Medical Standard of Care as Chronic Therapy for Non-splenectomized Subjects with Immune (Idiop... | |||||||||||||
Medical condition: Immune (idiopathic) thrombocytopenic purpura (ITP) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) GB (Completed) FR (Completed) PT (Completed) CZ (Completed) BE (Completed) DE (Completed) IT (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-005086-39 | Sponsor Protocol Number: BT-11-201 | Start Date*: 2019-10-28 | ||||||||||||||||
Sponsor Name:Landos Biopharma Inc. | ||||||||||||||||||
Full Title: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate Efficacy and Safety of Oral BT-11 in Mild to Moderate Ulcerative Colitis | ||||||||||||||||||
Medical condition: Mild to Moderate Ulcerative Colitis Inflammatory bowel disease (IBD) is an autoimmune disease of the gastrointestinal (GI) tract with unknown etiology that encompasses 2 primary clinical manifesta... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Completed) PL (Completed) HR (Completed) BG (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004812-40 | Sponsor Protocol Number: D2211C00001 | Start Date*: 2012-01-26 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A phase IIa, randomised, double-blind, placebo-controlled, parallel-arm, multicenter study to evaluate the efficacy and safety of tralokinumab (CAT-354), a recombinant human monoclonal antibody dir... | |||||||||||||
Medical condition: Ulcerative Colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) NL (Prematurely Ended) CZ (Completed) IT (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002306-12 | Sponsor Protocol Number: GB004-2101 | Start Date*: 2021-01-12 | |||||||||||
Sponsor Name:GB004, Inc. | |||||||||||||
Full Title: A Phase 2, randomized, double-blind, placebo-controlled, multi-center study to evaluate GB004 in adult subjects with mild-to-moderate active ulcerative colitis | |||||||||||||
Medical condition: Mild-to-moderate active ulcerative colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Prematurely Ended) RO (Ongoing) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.